Across TCGA pan-cancer cohorts, LINC00866 RNA differs between tumor and matched normal tissue in 11 of 18 cancer types tested, making tumor–normal expression one of LINC00866’s most consistent transcriptional readouts.
The strongest signal is observed in lung adenocarcinoma (LUAD), where LINC00866 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types LINC00866 is over-expressed in tumor, although a few such as BRCA show the opposite, repressed pattern.
LUAD, THCA, and LIHC are the cancer types where LINC00866 tumor–normal differential expression is most reproducible.
RNA tumor vs normal associations by lineage
Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC00866 RNA (log2); positive values indicate higher expression in tumor. p-values are from the differential-expression test.